Notably, this comes as the FDA introduced a so-called Green List in September 2025: a mechanism aimed at preventing potentially unsafe active pharmaceutical ingredients (APIs) from unverified foreign sources, particularly those for GLP-1 drugs, from entering the U.S
Grasping Patient Rights in Product Liability Cases When pharmaceutical treatments cause harm due to deviations from safety standards, patients may have grounds for product liability claims
Disqualifying conditions include a history of Diabetes, Kidney Disease, Gallbladder Disease, Pancreatitis, Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Syndrome Type 2, Thyroid Nodule that has not been evaluated, Pregnant or Breastfeeding Medical studies report patients losing 15-20% of their body weight on average after one year
Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes
Peptides for muscle growth complement this training but don't replace it
